Growth Metrics

Endava (DAVA) Cash & Equivalents (2017 - 2025)

Endava's Cash & Equivalents history spans 9 years, with the latest figure at $91.1 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 18.16% to $91.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $91.1 million through Dec 2025, up 18.16% year-over-year, with the annual reading at $79.2 million for FY2025, 66.99% down from the prior year.
  • Cash & Equivalents came in at $91.1 million for Q4 2025, up from $80.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $246.5 million in Q4 2023 to a low of $77.1 million in Q4 2024.
  • The 5-year median for Cash & Equivalents is $137.3 million (2021), against an average of $153.7 million.
  • Year-over-year, Cash & Equivalents surged 130.74% in 2022 and then crashed 68.72% in 2024.
  • Endava's Cash & Equivalents stood at $94.2 million in 2021, then soared by 130.74% to $217.4 million in 2022, then rose by 13.4% to $246.5 million in 2023, then plummeted by 68.72% to $77.1 million in 2024, then increased by 18.16% to $91.1 million in 2025.
  • Per Business Quant, the three most recent readings for DAVA's Cash & Equivalents are $91.1 million (Q4 2025), $80.1 million (Q3 2025), and $79.2 million (Q2 2025).